BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 23503452)

  • 1. Comparison of a stable isotope-labeled and an analog internal standard for the quantification of everolimus by a liquid chromatography-tandem mass spectrometry method.
    Heideloff C; Payto D; Wang S
    Ther Drug Monit; 2013 Apr; 35(2):246-50. PubMed ID: 23503452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of performance of new, isotopically labeled internal standard ([13c2d4]RAD001) for everolimus using a novel high-performance liquid chromatography tandem mass spectrometry method.
    Korecka MA; Patel R; Shaw LM
    Ther Drug Monit; 2011 Aug; 33(4):460-3. PubMed ID: 21743385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive quantification of sirolimus and everolimus by LC-MS/MS with online sample cleanup.
    Mueller DM; Rentsch KM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(13-14):1007-12. PubMed ID: 20308022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra fast liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of cyclosporin A, tacrolimus, sirolimus, and everolimus in whole blood using deuterated internal standards for cyclosporin A and everolimus.
    Meinitzer A; Gartner G; Pilz S; Stettin M
    Ther Drug Monit; 2010 Feb; 32(1):61-6. PubMed ID: 20010460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the effect of isotopically labeled or structural analog internal standards on the performance of a LC-MS/MS method to determine ciclosporin A, everolimus, sirolimus and tacrolimus in whole blood.
    Valbuena H; Shipkova M; Kliesch SM; Müller S; Wieland E
    Clin Chem Lab Med; 2016 Mar; 54(3):437-46. PubMed ID: 26351941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A direct method for the measurement of everolimus and sirolimus in whole blood by LC-MS/MS using an isotopic everolimus internal standard.
    Morgan PE; Brown NW; Tredger JM
    Ther Drug Monit; 2014 Jun; 36(3):358-65. PubMed ID: 24305629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the MassTrak Immunosuppressant XE Kit for the determination of everolimus and cyclosporin A in human whole blood employing isotopically labeled internal standards.
    Ji M; Kim S; Chung HJ; Lee W; Chun S; Min WK
    Clin Chem Lab Med; 2011 Dec; 49(12):2021-7. PubMed ID: 21756161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood.
    McMillin GA; Johnson-Davis K; Dasgupta A
    Ther Drug Monit; 2012 Apr; 34(2):222-6. PubMed ID: 22322402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
    Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a novel commercial assay for the determination of cyclosporine A, tacrolimus, sirolimus, and everolimus by liquid chromatography-tandem mass spectrometric assay.
    Becker S; Thiery J; Ceglarek U
    Ther Drug Monit; 2013 Feb; 35(1):129-32. PubMed ID: 23188181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of cyclosporine, tacrolimus, sirolimus and everolimus by liquid chromatography coupled to electrospray ionization and tandem mass spectrometry: assessment of matrix effects and assay performance.
    Vethe NT; Gjerdalen LC; Bergan S
    Scand J Clin Lab Invest; 2010 Dec; 70(8):583-91. PubMed ID: 21039189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput LC-MS/MS method for monitoring sirolimus and everolimus in the routine clinical laboratory.
    Ivanova M; Artusi C; Polo G; Zaninotto M; Plebani M
    Clin Chem Lab Med; 2011 Jul; 49(7):1151-8. PubMed ID: 21574883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
    Koster RA; Alffenaar JW; Greijdanus B; Uges DR
    Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of four immunosuppressive drugs in whole blood using MEPS and LC-MS/MS allowing automated sample work-up and analysis.
    Said R; Pohanka A; Abdel-Rehim M; Beck O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 897():42-9. PubMed ID: 22542514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
    Koster RA; Dijkers EC; Uges DR
    Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An isotope dilution LC-MS/MS based candidate reference method for the quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human whole blood.
    Taibon J; van Rooij M; Schmid R; Singh N; Albrecht E; Anne Wright J; Geletneky C; Schuster C; Mörlein S; Vogeser M; Seger C; Pongratz S; Kobold U
    Clin Biochem; 2020 Aug; 82():73-84. PubMed ID: 31770523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus method comparison between Waters MassTrak™ Immunosuppressants XE (IUO) kit and an in-house laboratory developed LC-MS/MS method in renal transplant patients.
    Johnson-Davis KL; Juenke JM; Thomas RL; Bradshaw T
    Ann Clin Lab Sci; 2015; 45(1):27-31. PubMed ID: 25696007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
    Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
    Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry.
    Bronsema KJ; Bischoff R; van de Merbel NC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():1-14. PubMed ID: 22426285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
    Hoffer E; Kurnik D; Efrati E; Scherb I; Karasik M; Ring G; Bentur Y
    Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.